BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Casadó-anguera V, Cortés A, Casadó V, Moreno E. Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs. Expert Opinion on Drug Discovery 2019;14:1297-312. [DOI: 10.1080/17460441.2019.1664469] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Casadó-Anguera V, Casadó V. Unmasking allosteric binding sites: Novel targets for GPCR drug discovery. Expert Opin Drug Discov 2022. [PMID: 35649692 DOI: 10.1080/17460441.2022.2085684] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Pulido D, Casadó-Anguera V, Gómez-Autet M, Llopart N, Moreno E, Casajuana-Martin N, Ferré S, Pardo L, Casadó V, Royo M. Heterobivalent Ligand for the Adenosine A2A-Dopamine D2 Receptor Heteromer. J Med Chem 2022;65:616-32. [PMID: 34982555 DOI: 10.1021/acs.jmedchem.1c01763] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Casadó-Anguera V, Moreno E, Sánchez-Soto M, Cai NS, Bonaventura J, Homar-Ruano P, Rubinstein M, Cortés A, Canela EI, Ferré S, Casadó V. Heteromerization between α(2A) adrenoceptors and different polymorphic variants of the dopamine D(4) receptor determines pharmacological and functional differences. Implications for impulsive-control disorders. Pharmacol Res 2021;170:105745. [PMID: 34182128 DOI: 10.1016/j.phrs.2021.105745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Viaro R, Longo F, Vincenzi F, Varani K, Morari M. l-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter. Brain Res 2021;1768:147583. [PMID: 34284020 DOI: 10.1016/j.brainres.2021.147583] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gallo M, Moreno E, Defaus S, Ortega-Alvaro A, Gonzalez A, Robledo P, Cavaco M, Neves V, Castanho MARB, Casadó V, Pardo L, Maldonado R, Andreu D. Orally Active Peptide Vector Allows Using Cannabis to Fight Pain While Avoiding Side Effects. J Med Chem 2021;64:6937-48. [PMID: 33887904 DOI: 10.1021/acs.jmedchem.1c00484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Shchepinova MM, Hanyaloglu AC, Frost GS, Tate EW. Chemical biology of noncanonical G protein-coupled receptor signaling: Toward advanced therapeutics. Curr Opin Chem Biol 2020;56:98-110. [PMID: 32446179 DOI: 10.1016/j.cbpa.2020.04.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]